1 minute reading time (53 words)

U.S. FDA Approves Athena Bioscience's New Drug Application (NDA) for QDOLO™ (tramadol hydrochloride) Oral Solution

Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved QDOLO™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Full story.

Related Posts

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More